1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5):E359–E386. PMID:
25220842.
2. Khanderia E, Markar SR, Acharya A, Kim Y, Kim YW, Hanna GB. The influence of gastric cancer screening on the stage at diagnosis and survival: a meta-analysis of comparative studies in the far east. J Clin Gastroenterol. 2016; 50(3):190–197. PMID:
26844858.
3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer;2014.
4. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002; 50(3):378–381. PMID:
11839718.
5. Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, et al. Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea. J Gastroenterol Hepatol. 2012; 27(5):928–934. PMID:
22142434.
6. National cancer control programs in Korea. J Korean Med Sci. 2007; 22(Suppl):S3–S4. PMID:
18077892.
7. Shiratori Y, Nakagawa S, Kikuchi A, Ishii M, Ueno M, Miyashita T, et al. Significance of a gastric mass screening survey. Am J Gastroenterol. 1985; 80(11):831–834. PMID:
4050756.
8. Mori Y, Arita T, Shimoda K, Yasuda K, Yoshida T, Kitano S. Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival. Gastric Cancer. 2001; 4(3):132–136. PMID:
11760078.
9. Nam SY, Choi IJ, Park KW, Kim CG, Lee JY, Kook MC, et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol. 2009; 21(8):855–860. PMID:
19369882.
10. Park CH, Kim EH, Chung H, Lee H, Park JC, Shin SK, et al. The optimal endoscopic screening interval for detecting early gastric neoplasms. Gastrointest Endosc. 2014; 80(2):253–259. PMID:
24613579.
11. Nam JH, Choi IJ, Cho SJ, Kim CG, Jun JK, Choi KS, et al. Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer. 2012; 118(20):4953–4960. PMID:
22806878.
12. Murakami T. Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Jpn J Cancer Res. 1971; 11:53–55.
13. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010; 17(12):3077–3079. PMID:
20882416.
14. Fléjou JF. WHO Classification of digestive tumors: the fourth edition. Ann Pathol. 2011; 31(5 Suppl):S27–S31. PMID:
22054452.
15. Choi IJ, Lee JH, Kim YI, Kim CG, Cho SJ, Lee JY, et al. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc. 2015; 81(2):333–341.e1. PMID:
25281498.
16. Kim JM, Sohn JH, Cho MY, Kim WH, Chang HK, Jung ES, et al. Pre- and post-ESD discrepancies in clinicopathologic criteria in early gastric cancer: the NECA-Korea ESD for Early Gastric Cancer Prospective Study (N-Keep). Gastric Cancer. 2016; 19(4):1104–1113. PMID:
26621523.
17. Choi IJ. Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc. 2014; 47(6):497–503. PMID:
25505714.
18. Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer. 2002; 5(3):177–182. PMID:
12378346.
19. Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg. 2000; 85(4):286–290. PMID:
11589593.
20. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014; 46(2):109–123. PMID:
24851102.
21. Riecken B, Pfeiffer R, Ma JL, Jin ML, Li JY, Liu WD, et al. No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med. 2002; 34(1):22–28. PMID:
11749093.
22. Kim YS, Park HA, Kim BS, Yook JH, Lee MS. Efficacy of screening for gastric cancer in a Korean adult population: a case-control study. J Korean Med Sci. 2000; 15(5):510–515. PMID:
11068986.
23. Lee H, Min BH, Lee JH, Son HJ, Kim JJ, Rhee JC, et al. Survival outcome associated with the screening interval for gastric cancer in Korea. Digestion. 2011; 84(2):142–148. PMID:
21525769.
24. Kim J, Kim SM, Ha MH, Seo JE, Choi MG, Lee JH, et al. Does the interval of screening endoscopy affect survival in gastric cancer patients?: a cross-sectional study. Medicine (Baltimore). 2016; 95(49):e5490. PMID:
27930534.
25. Pimenta-Melo AR, Monteiro-Soares M, Libânio D, Dinis-Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016; 28(9):1041–1049. PMID:
27148773.
26. Menon S, Trudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis. Endosc Int Open. 2014; 2(2):E46–E50. PMID:
26135259.
27. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24):6735–6740. PMID:
1458460.
28. Lansdown M, Quirke P, Dixon MF, Axon AT, Johnston D. High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut. 1990; 31(9):977–983. PMID:
2210465.
29. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008; 134(4):945–952. PMID:
18395075.